NARCAN

This brand name is authorized in United States. It is also authorized in Australia, Brazil, Canada, France.

Active ingredients

The drug NARCAN contains one active pharmaceutical ingredient (API):

1	Naloxone UNII F850569PQR - NALOXONE HYDROCHLORIDE
	Naloxone hydrochloride, a semisynthetic morphine derivative (N-allyl-nor-oxymorphone), is a specific opioid antagonist that acts competitively at opioid receptors. It reveals very high affinity for the opioid receptor sites and therefore displaces both opioid agonists and partial antagonists, such as pentazocine, for example, but also nalorphine.
	Read more about Naloxone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NARCAN NALOXONE HCI	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V03AB15	Naloxone	V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes
Discover more medicines within V03AB15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11233F
BR	Câmara de Regulação do Mercado de Medicamentos	506709901152411, 506715020056003, 506717070070603
CA	Health Products and Food Branch	02458187
FR	Base de données publique des médicaments	64117646
US	FDA, National Drug Code	51662-1240, 55700-457, 69547-212, 69547-353